Duncan McHale's Insider Trades & SAST Disclosures

Duncan McHale's most recent trade in Evelo Biosciences Inc was a trade of 6,500 Restricted Stock Units done . Disclosure was reported to the exchange on Aug. 7, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2023 6,500 13,000 - - Restricted Stock Units
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Aug 2023 6,500 11,375 (0%) 0% - Common Stock
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Sale of securities on an exchange or to another person at price $ 9.51 per share. 07 Aug 2023 3,434 7,941 (0%) 0% 9.5 32,657 Common Stock
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.13 per share. 08 May 2023 66,730 97,516 (0%) 0% 0.1 8,375 Common Stock
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2023 130,000 390,000 - - Restricted Stock Units
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2023 130,000 164,246 (0%) 0% - Common Stock
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2023 520,000 520,000 - - Restricted Stock Units
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 1.46 per share. 27 May 2022 34,246 34,246 (0%) 0% 1.5 49,999 Common Stock
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2022 100,000 100,000 - - Stock Option (Right to Buy)
Evelo Biosciences Inc
Duncan McHale Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2021 96,500 96,500 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades